CONMED CORPORATION Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
CONMED CORPORATION (CNMD) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of $14.94 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2026-02-17
- CONMED CORPORATION effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2025 was $14.94M, a 56.38% decline from fiscal 2024.
- CONMED CORPORATION effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2024 was $34.24M, a 101.70% increase from fiscal 2023.
- CONMED CORPORATION effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2023 was $16.97M.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month |
|---|---|
| 2025-12-31 | $14.94M 10-K · filed 2026-02-17 |
| 2024-12-31 | $34.24M 10-K · filed 2026-02-17 |
| 2023-12-31 | $16.97M 10-K · filed 2026-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |